RxDoctor Payments Data

Frederick Heard, MD

Family Medicine · Shreveport, LANPI 1972536068

Payments from drug & device makers

$604in general payments, 2019–2025

Across 16 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$331
  • Indivior Inc.$68
  • Bayer$38
  • AbbVie$38
  • AstraZeneca$36
  • Merck$25
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$604 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$14,188
Medicare patients
87
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin46$44,788
JanuviaSitagliptin Phosphate17$22,906
OzempicSemaglutide19$18,026
Breo ElliptaFluticasone/Vilanterol28$14,213
FarxigaDapagliflozin Propanediol13$13,367
Combivent RespimatIpratropium/Albuterol Sulfate20$12,547
EntrestoSacubitril/Valsartan11$12,512
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$5,360
Albuterol Sulfate HfaAlbuterol Sulfate98$2,990
Esomeprazole Magnesium20$2,445
Atorvastatin Calcium212$1,922
Omeprazole141$1,465
Gabapentin75$1,002
Amlodipine Besylate243$915
Enalapril Maleate19$702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$25$22,90617 claims
Novo NordiskOzempic$18$18,02619 claims
AstraZenecaFarxiga$36$13,36713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →